Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Autophagy and multidrug resistance in cancer
Yingjie Li, Yuhe Lei, Nan Yao, et al.
Chinese Journal of Cancer (2017) Vol. 36, Iss. 1
Open Access | Times Cited: 631

Showing 1-25 of 631 citing articles:

Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing, Fengming Yang, Chuchu Shao, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 1582
Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
Zhenru Xu, Xu Han, Daming Ou, et al.
Applied Microbiology and Biotechnology (2019) Vol. 104, Iss. 2, pp. 575-587
Closed Access | Times Cited: 468
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
Nuray Erin, Jelena Grahovac, Anamaria Brozović, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100715-100715
Open Access | Times Cited: 391
Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies
Jianlei Xie, Yingwei Wang, Wonseok Choi, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 16, pp. 9152-9201
Closed Access | Times Cited: 381
Understanding of ROS-Inducing Strategy in Anticancer Therapy
Su Ji Kim, Hyun Soo Kim, Young Rok Seo
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 351
Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 616-616
Open Access | Times Cited: 306
An overview of autophagy: Mechanism, regulation and research progress
Weiya Cao, Jinhong Li, Kepeng Yang, et al.
Bulletin du Cancer (2021) Vol. 108, Iss. 3, pp. 304-322
Closed Access | Times Cited: 304
The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine Sulfonamide Derivatives on Apoptosis and Autophagy in DLD-1 and HT-29 Colon Cancer Cells
Agnieszka Gornowicz, Anna Szymanowska, Mariusz Mojzych, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5221-5221
Open Access | Times Cited: 293
Natural products as multidrug resistance modulators in cancer
Amit Kumar, Vikas Jaitak
European Journal of Medicinal Chemistry (2019) Vol. 176, pp. 268-291
Closed Access | Times Cited: 283
Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Yuan Li, Zhiyuan Xu, Shanming Ruan, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 266
Drug resistance in cancer: mechanisms and tackling strategies
Tanweer Haider, Vikas Pandey, Nagma Banjare, et al.
Pharmacological Reports (2020) Vol. 72, Iss. 5, pp. 1125-1151
Closed Access | Times Cited: 220
Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells
Kaja Urbańska, Arkadiusz Orzechowski
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2085-2085
Open Access | Times Cited: 208
Autophagy and doxorubicin resistance in cancer
Chao Chen, Lu Lu, Shichao Yan, et al.
Anti-Cancer Drugs (2017) Vol. 29, Iss. 1, pp. 1-9
Closed Access | Times Cited: 186
Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis
Xiao-Hua Yu, Dawei Zhang, Xi‐Long Zheng, et al.
Progress in Lipid Research (2018) Vol. 73, pp. 65-91
Closed Access | Times Cited: 183
Molecular and cellular paradigms of multidrug resistance in cancer
Foram U. Vaidya, Abu Sufiyan Chhipa, Vinita Mishra, et al.
Cancer Reports (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 161
Therapeutic strategies to overcome taxane resistance in cancer
Tuyelee Das, Uttpal Anand, Swaroop Kumar Pandey, et al.
Drug Resistance Updates (2021) Vol. 55, pp. 100754-100754
Closed Access | Times Cited: 159
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
Yang Yang, Shuo Li, Yujiao Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 148
<p>Biological Roles and Mechanisms of Circular RNA in Human Cancers</p>
Qing Tang, Swei Sunny Hann
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 2067-2092
Open Access | Times Cited: 142
5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
Soudeh Ghafouri‐Fard, Atefe Abak, Farhad Tondro Anamag, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 120
Is targeting autophagy mechanism in cancer a good approach? The possible double-edge sword effect
Su Min Lim, Ezanee Azlina Mohamad Hanif, Siok‐Fong Chin
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 110
Functionalized liposomes for targeted breast cancer drug delivery
Janske Nel, Kamil Elkhoury, Émilie Velot, et al.
Bioactive Materials (2023) Vol. 24, pp. 401-437
Open Access | Times Cited: 108
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance
Hong Lin, Di Wang, Pinghan Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 84
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment
Michela Chiappa, Serena Petrella, Giovanna Damia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 83
Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells
Ying Zhu, Anni Wang, Shuya Zhang, et al.
Journal of Advanced Research (2022) Vol. 49, pp. 159-173
Open Access | Times Cited: 77
Kaempferol Can Reverse the 5-Fu Resistance of Colorectal Cancer Cells by Inhibiting PKM2-Mediated Glycolysis
Haili Wu, Jin’e Du, Chenglu Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3544-3544
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top